4 Results for "

DS1040

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DS1040" in MCE Product Catalog:

Cat. No.: HY-101918
CAS No.: 1335138-89-0
Purity:  99.51%
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

DS-1040 Tosylate is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-117745
CAS No.: 1335138-62-9
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

DS-1040 is a low-molecular-weight imidazole derivative. DS-1040 is an inhibitor of the activated thrombin-activatable fibrinolysis (TAFIa). DS-1040 can promote fibrinolysis through suppressing TAFIa activity. DS-1040 can be studied in thrombolytic disease research .
loading...
    loading...
Cat. No.: HY-101918R
CAS No.: 1335138-89-0
Research Areas:  

Cardiovascular Disease

DS-1040 Tosylate (Standard) is the analytical standard of DS-1040 Tosylate (HY-101918). This product is intended for research and analytical applications. DS-1040 Tosylate is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-179636
CAS No.: 1335138-79-8
Target:  

Drug Intermediate

Research Areas:  

Cardiovascular Disease

DS-1040 Tosylate prodrug-1 (Compound 2) is a prodrug of DS-1040 Tosylate (Compound 1) (HY-101918). DS-1040 Tosylate prodrug-1 can be used to study thromboembolic diseases .
loading...
    loading...